On a more serious note AUSTIN, TX, Nov. 01, 202
Post# of 22456
Quote:
AUSTIN, TX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- QMC Health Incorporated announced today an agreement with Lawson Health Research Institute for the exclusive rights to novel blood biomarkers that characterize Long COVID disease. The discovery of the biomarkers identified by a research team at Lawson , led by Dr. Douglas Fraser, was recently published in the journal, Molecular Medicine1. QMC Health will use these biomarkers to develop a Long COVID point-of-care rapid test based on its QDX™ HPFIS (High-Performance Fluorescent Immuno-Sensors) for high sensitivity bio-detection and quantification to develop a best-in-class, low-cost rapid diagnostic testing assay platform.
Quote:
Working in partnership with Western University , our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely
https://www.globenewswire.com/en/news-release...-Test.html
https://www.youtube.com/watch?v=buqs3ged9k8
Go to you tube search type in
Dr Douglas Fraser, western university, long term COVID
Rule out any video involving Dr Fraser, Western University and Long Term Covid before Nov 1 2022